胃癌患者外周血DPDmRNA的表达与替吉奥化疗不良反应的关系  

Relationship between the expression of DPD mRNA in peripheral blood and adverse drug reactions of S-1 chemotherapy in patients with ad-vanced gastric cancer

作　　者：袁聪[1] 廖娟[1] 

机构地区：[1]川北医学院附属医院消化内科,四川南充637000

出　　处：《中国医药导报》2014年第6期50-52,共3页China Medical Herald

摘　　要：目的 探讨二氢嘧啶脱氢酶（DPD）在外周血中转录水平与替吉奥化疗不良反应的关系.方法 选择川北医学院附属医院2011年1月～2013年6月失去手术根治机会或出现复发转移的54例晚期胃癌患者接受口服替吉奥化疗,采用逆转录聚合酶链反应（RT-PCR）方法检测患者外周血中DPD mRNA的表达,比较其表达与化疗不良反应的关系.结果 胃癌患者外周血DPD mRNA的表达与化疗引起的恶心呕吐、骨髓抑制、腹泻及口腔黏膜炎等不良反应无明显相关性（P＞0.05）.结论 胃癌患者替吉奥化疗的不良反应不受DPD mRNA表达的影响.Objective To explore the relationship between the transcription of dihydropyrimidine dehydrogenase （DPD） in peripheral blood （PB） and adverse drug reactions （ADRs） of S-1.Methods From January 2011 to June 2013,54 patients with advanced gastric cancer who lost the opportunities of radical surgery and recurrence or metastasis were administrated with S-1 orally in the Affiliated Hospital of North Sichuan Medical University.The reverse transcriptasepolymerase chain reaction （RT-PCR） was adopted to detect the expression of DPD mRNA in PB and its relationship with ADRs was compared.Results The expression of PB DPD mRNA had no obvious correlations with ADRs caused chemotherapy such as nausea,vomiting,myelosuppression,diarrhea and oral mucositis （P 〉 0.05）.Conclusion DPD mRNA expression has no influence on the ADRs caused by S-1 in patients with advanced gastric cancer.

关 键 词：二氢嘧啶脱氢酶 替吉奥 胃癌 不良反应 

分 类 号：R735.2[医药卫生—肿瘤]